PYSTYNEN; Jarmo

Patent Applications and Registrations

Patent applications and USPTO patent grants for PYSTYNEN; Jarmo.The latest application filed is for "catechol o-methyltransferase activity inhibiting compounds".

Company Profile

5.8.15

PYSTYNEN; Jarmo - Espoo FI

*profile and listings may contain filings by different individuals or companies with the same name. Review application materials to confirm ownership/assignment.

Patent Activity

Patent	Date
Catechol O-methyltransferase Activity Inhibiting Compounds App 20220047540 - AHLMARK; Marko ; et al.	2022-02-17
Process For The Preparation Of 4,5-dihydroxy-2-(4-methylbenzyl)isophthalonitrile App 20220002232 - KUMPULAINEN; Esa ; et al.	2022-01-06
Catechol O-methyltransferase Activity Inhibiting Compounds App 20200352898 - AHLMARK; Marko ; et al.	2020-11-12
2-(1-heteroarylpiperazin-4-yl)methyl-1,4-benzodioxane derivatives as alpha2C antagonists Grant 10,774,074 - Wang , et al. Sept	2020-09-15
2-(1-heteroarylpiperazin-4-yl)methyl-1,4-benzodioxane Derivatives As Alpha2c Antagonists App 20190292170 - WANG; Shouming ; et al.	2019-09-26
Benzodioxane Derivatives And Their Pharmaceutical Use App 20190152992 - HAIKARAINEN; Anssi ; et al.	2019-05-23
Catechol O-methyltransferase Activity Inhibiting Compounds App 20190029990 - Ahlmark; Marko ; et al.	2019-01-31
2-(1-heteroarylpiperazin-4-yl)methyl-1,4-benzodioxane Derivatives As Alpha2c Antagonists App 20180215739 - WANG; Shouming ; et al.	2018-08-02
Catechol O-methyltransferase Activity Inhibiting Compounds App 20170165219 - AHLMARK; Marko ; et al.	2017-06-15
Catechol O-methyltransferase activity inhibiting compounds Grant 9,458,128 - Ahlmark , et al. October 4, 2	2016-10-04
Catechol O-methyltransferase Activity Inhibiting Compounds App 20150218124 - Ahlmark; Marko ; et al.	2015-08-06
Pharmaceutical compounds Grant 8,318,785 - Ahlmark , et al. November 27, 2	2012-11-27
Pharmaceutical Compounds App 20110086852 - AHLMARK; Marko ; et al.	2011-04-14
Pharmaceutical Compounds App 20090209532 - Ahlmark; Marko ; et al.	2009-08-20
Coumarin derivatives with COMT inhibiting activity Grant 6,951,870 - Pystynen , et al. October 4, 2	2005-10-04
Derivatives of naphthalene with COMT inhibiting activity Grant 6,903,114 - Backstrom , et al. June 7, 2	2005-06-07
Coumarin derivatives with comt inhibiting activity App 20040110750 - Pystynen, Jarmo ; et al.	2004-06-10
Pyridazinyl phenyl hydrazones useful against congestive heart failure Grant 6,699,868 - Pystynen , et al. March 2, 2	2004-03-02
Derivatives of naphthalene with comt inhibiting activity App 20040034011 - Bckstrom, Reijo ; et al.	2004-02-19
Coumarin derivatives with comt inhibiting activity App 20030186975 - Pystynen, Jarmo ; et al.	2003-10-02
Pyridazinyl phenyl hydrazones useful against congestive heart failure App 20030158200 - Pystynen, Jarmo ; et al.	2003-08-21
Catechol derivatives Grant 6,150,412 - Pystynen , et al. November 21, 2	2000-11-21
Method of treating Parkinson's Disease using pentanedione derivatives Grant 5,112,861 - Backstrom , et al. May 12, 1	1992-05-12

uspto.report is an independent third-party trademark research tool that is not affiliated, endorsed, or sponsored by the United States Patent and Trademark Office (USPTO) or any other governmental organization. The information provided by uspto.report is based on publicly available data at the time of writing and is intended for informational purposes only.

While we strive to provide accurate and up-to-date information, we do not guarantee the accuracy, completeness, reliability, or suitability of the information displayed on this site. The use of this site is at your own risk. Any reliance you place on such information is therefore strictly at your own risk.

All official trademark data, including owner information, should be verified by visiting the official USPTO website at www.uspto.gov. This site is not intended to replace professional legal advice and should not be used as a substitute for consulting with a legal professional who is knowledgeable about trademark law.